search.noResults

search.searching

dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
Infection Control & Hospital Epidemiology (2018), 39, 897–901 doi:10.1017/ice.2018.137


Original Article


Centers for medicare and medicaid services hospital-acquired conditions policy for central line-associated bloodstream infection (CLABSI) and cather-associated urinary tract infection (CAUTI) shows minimal impact on hospital reimbursement


Michael S. Calderwood MD, MPH1, Alison Tse Kawai ScD2, Robert Jin MS2 and Grace M. Lee MD, MPH2,3 1Section of Infectious Disease and International Health, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, 2Department of Population Medicine,


Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts and 3Department of Pediatrics, Stanford University School of Medicine, Stanford, California


Abstract


Objective: In 2008, the Centers for Medicare and Medicaid Services (CMS) stopped reimbursing for hospital-acquired conditions (HACs) not present on admission (POA). We sought to understand why this policy did not impact central line–associated bloodstream infection (CLABSI) and catheter-associated urinary tract infection (CAUTI) trends. Design: Retrospective cohort study. Setting: Acute-care hospitals in the United States. Participants: Fee-for-service Medicare patients discharged January 1, 2007, through December 31, 2011. Methods: Using inpatient Medicare claims data, we analyzed billing practices before and after the HAC policy was implemented, including the use and POA designation of codes for CLABSI or CAUTI. For the 3-year period following policy implementation, we determined the impact on diagnosis-related groups (DRG) determining reimbursement as well as hospital characteristics associated with the reimbursement impact. Results: During the study period, 65,205,607 Medicare fee-for-service hospitalizations occurred at 3,291 acute-care, nonfederal US hospitals. Based on coding, CLABSI and CAUTI affected 0.23% and 0.06% of these hospitalizations, respectively. In addition, following the HAC policy, 82% of the CLABSI codes and 91% of the CAUTI codes were marked POA, which represented a large increase in the use of this designation. Finally, for the small numbers of CLABSI and CAUTI coded as not POA, financial impacts were detected on only 0.4% of the hospitalizations with a CLABSI code and 5.7% with a CAUTI code. Conclusions: Part of the reason the HAC policy did not have its intended impact is that billing codes for CLABSI and CAUTI were rarely used, were commonly listed as POA in the postpolicy period, and infrequently impacted hospital reimbursement.


(Received 27 February 2018; accepted 12 May 2018; electronically published June 28, 2018)


To encourage hospitals to invest in quality improvement, the Centers for Medicare and Medicaid Services (CMS) made changes to the Hospital Inpatient Prospective Payment System (IPPS) in 2008. Under these changes, CMS stopped allowing diagnosis codes for hospital-acquired conditions (HACs), such as central line–associated bloodstream infections (CLABSIs) and catheter- associated urinary tract infections (CAUTIs), to qualify for Medicare reimbursement.1 Under IPPS rules, reimbursement for an inpatient hospitalization is determined by the relative weight of billing codes used to assign diagnosis-related groups (DRGs).2


Author for correspondence: Michael S. Calderwood, MD, MPH, Section of Infectious


Disease and International Health, Dartmouth-Hitchcock Medical Center, One Medical Center Drive, Suite 5C, Lebanon, NH 03756. E-mail: Michael.S.Calderwood@hitchcock.org Cite this article: Calderwood MS, et al. (2018). Centers for medicare and medicaid


services hospital-acquired conditions policy for central line-associated bloodstream infection (CLABSI) and cather-associated urinary tract infection (CAUTI) shows minimal impact on hospital reimbursement. Infection Control & Hospital Epidemiology 2018, 39, 897–901. doi: 10.1017/ice.2018.137


© 2018 by The Society for Healthcare Epidemiology of America. All rights reserved.


By ceasing additional reimbursement for codes associated with CLABSI and CAUTI, it was hypothesized that hospitals would be driven to quickly reduce their HACs.3 Prior work, however, found that the CMS HAC policy did


not impact already declining national rates of CLABSIs and CAUTIs.4 While the CMS HAC policy did get the attention of hospital leadership and focused attention on healthcare-associated infections,5,6 surveys found that more effort was focused on the documentation of conditions present on admission (POA) rather than on implementing practice changes.5 Concern was also raised that differences across hospitals were more a reflection of differ- ences in coding practices rather than differences in quality.7 To further understand why the CMS HAC policy may not


have had its intended outcome, we studied the impact of this policy on the DRG assignment for Medicare hospitalizations with coded CLABSI and CAUTI events. Furthermore, we examined changes in coding practices following the implementation of the CMS HAC policy.

Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100  |  Page 101  |  Page 102  |  Page 103  |  Page 104  |  Page 105  |  Page 106  |  Page 107  |  Page 108  |  Page 109  |  Page 110  |  Page 111  |  Page 112  |  Page 113  |  Page 114  |  Page 115  |  Page 116  |  Page 117  |  Page 118  |  Page 119  |  Page 120  |  Page 121  |  Page 122  |  Page 123  |  Page 124  |  Page 125  |  Page 126  |  Page 127  |  Page 128  |  Page 129  |  Page 130  |  Page 131  |  Page 132  |  Page 133  |  Page 134  |  Page 135  |  Page 136  |  Page 137  |  Page 138  |  Page 139  |  Page 140